Gemcitabine Kabi

Gemcitabine Hydrochloride is a chemotherapy medication used to treat various cancers. This intravenous drug is manufactured by Fresenius Kabi Polska Sp. Z O.O. and is available in the EU market.

Gemcitabine Hydrochloride is primarily used in the treatment of certain types of cancer. It works by slowing or stopping the growth of cancer cells in the body. This medication is often prescribed for conditions such as pancreatic cancer, non-small cell lung cancer, and breast cancer. Patients should consult their healthcare provider to understand what is Gemcitabine Hydrochloride used for in their specific case.

Common effects of Gemcitabine Hydrochloride may include fatigue, nausea, and vomiting. Some patients might experience hair loss, loss of appetite, or changes in skin color. These effects can vary from person to person and may not affect everyone who takes the medication.

Gemcitabine Hydrochloride should be handled with care and administered by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Gemcitabine Hydrochloride may interact with other medications, including those that suppress the immune system or affect blood cell production. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of this medication.